Scienture Holdings, Inc. announced a securities purchase agreement with institutional investors for 3,225,000 shares of common stock at $1.20 per share.
The gross proceeds for the offering are expected to be approximately $3.9 million before expenses.
The offering is set to close on August 15, 2025, subject to customary conditions.
Offering Details
3,225,000 shares of common stock at $1.20 per share.
Gross Proceeds
Expected to be approximately $3.9 million before expenses.
Closing Date
Expected to be August 15, 2025, subject to customary conditions.
- This offering provides Scienture Holdings with significant capital to support its business operations and growth initiatives.
- The involvement of institutional investors showcases confidence in Scienture's future prospects and product offerings.
The successful completion of this offering is a positive indicator of investor interest in Scienture Holdings and its pharmaceutical products.